S.L.A. Pharma AG
SLA Pharma is a global pharmaceutical company specializing in gastrointestinal health. With over 30 years of experience, they focus on developing innovative, targeted therapies for GI disorders, including gastrointestinal oncology and proctology. Their mission is to improve patient lives through rigorous research, patient-centered innovation, and strategic partnerships worldwide.
Industries
Nr. of Employees
small (1-50)
S.L.A. Pharma AG
Strategic locations across Europe, including Switzerland, UK, and Ireland
Products
Market-ready formulations for gastrointestinal therapies
Formulations positioned for regulatory submission and commercial distribution in gastrointestinal therapeutic areas.
Clinically validated gastrointestinal therapies
Therapeutic products supported by clinical research and trials focused on digestive health, GI oncology and proctology.
Market-ready formulations for gastrointestinal therapies
Formulations positioned for regulatory submission and commercial distribution in gastrointestinal therapeutic areas.
Clinically validated gastrointestinal therapies
Therapeutic products supported by clinical research and trials focused on digestive health, GI oncology and proctology.
Services
Design and conduct of clinical trials for gastrointestinal therapies using a global research network and streamlined trial processes.
Regulatory strategy development, identification of accelerated approval routes and preparation of regulatory and technical documentation to support registration.
Out-licensing and in-licensing arrangements, flexible licensing models and commercial partnership development to enable market entry and distribution.
Collaborative research with international institutions, key opinion leaders and healthcare providers to advance gastrointestinal therapeutic development.
Design and conduct of clinical trials for gastrointestinal therapies using a global research network and streamlined trial processes.
Regulatory strategy development, identification of accelerated approval routes and preparation of regulatory and technical documentation to support registration.
Out-licensing and in-licensing arrangements, flexible licensing models and commercial partnership development to enable market entry and distribution.
Collaborative research with international institutions, key opinion leaders and healthcare providers to advance gastrointestinal therapeutic development.
Expertise Areas
- Gastroenterology therapeutics
- Drug repurposing and indication expansion
- Clinical trial management and global site network
- Regulatory strategy and market access
Key Technologies
- Drug repurposing methodologies
- Formulation development
- Clinical trial management systems and networks
- Regulatory pathway identification and submission strategy